57 related articles for article (PubMed ID: 9599405)
1. Extracellular degradation of agonists as an adaptive mechanism.
Ladds G; Hughes M; Davey J
Semin Cell Dev Biol; 1998 Apr; 9(2):111-8. PubMed ID: 9599405
[TBL] [Abstract][Full Text] [Related]
2. Role of the extracellular amino terminus and first membrane-spanning helix of dopamine D1 and D5 receptors in shaping ligand selectivity and efficacy.
D'Aoust JP; Tiberi M
Cell Signal; 2010 Jan; 22(1):106-16. PubMed ID: 19786093
[TBL] [Abstract][Full Text] [Related]
3. B-lymphoma cells are activated by peptide ligands of the antigen binding receptor or by anti-idiotypic antibody to induce extracellular acidification.
Renschler MF; Wada HG; Fok KS; Levy R
Cancer Res; 1995 Dec; 55(23):5642-7. PubMed ID: 7585648
[TBL] [Abstract][Full Text] [Related]
4. Expression and purification of the extracellular ligand-binding domain of the atrial natriuretic peptide (ANP) receptor: monovalent binding with ANP induces 2:2 complexes.
Misono KS; Sivasubramanian N; Berkner K; Zhang X
Biochemistry; 1999 Jan; 38(2):516-23. PubMed ID: 9888790
[TBL] [Abstract][Full Text] [Related]
5. The extracellular glycosphingolipid-binding motif of Fas defines its internalization route, mode and outcome of signals upon activation by ligand.
Chakrabandhu K; Huault S; Garmy N; Fantini J; Stebe E; Mailfert S; Marguet D; Hueber AO
Cell Death Differ; 2008 Dec; 15(12):1824-37. PubMed ID: 18670435
[TBL] [Abstract][Full Text] [Related]
6. Photolabelling the urotensin II receptor reveals distinct agonist- and partial-agonist-binding sites.
Holleran BJ; Beaulieu ME; Proulx CD; Lavigne P; Escher E; Leduc R
Biochem J; 2007 Feb; 402(1):51-61. PubMed ID: 17064254
[TBL] [Abstract][Full Text] [Related]
7. Conformational adaptation of nuclear receptor ligand binding domains to agonists: potential for novel approaches to ligand design.
Togashi M; Borngraeber S; Sandler B; Fletterick RJ; Webb P; Baxter JD
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):127-37. PubMed ID: 15860255
[TBL] [Abstract][Full Text] [Related]
8. Down regulation of yeast G protein-coupled receptors.
Riezman H
Semin Cell Dev Biol; 1998 Apr; 9(2):129-34. PubMed ID: 9599407
[TBL] [Abstract][Full Text] [Related]
9. Cell receptors: definition, mechanisms and regulation of receptor-mediated endocytosis.
Féger J; Gil-Falgon S; Lamaze C
Cell Mol Biol (Noisy-le-grand); 1994 Dec; 40(8):1039-61. PubMed ID: 7873978
[TBL] [Abstract][Full Text] [Related]
10. Issues of ligand accessibility and mobility in initial cell attachment.
Thid D; Bally M; Holm K; Chessari S; Tosatti S; Textor M; Gold J
Langmuir; 2007 Nov; 23(23):11693-704. PubMed ID: 17918863
[TBL] [Abstract][Full Text] [Related]
11. Specificity of the thrombin receptor for agonist peptide is defined by its extracellular surface.
Gerszten RE; Chen J; Ishii M; Ishii K; Wang L; Nanevicz T; Turck CW; Vu TK; Coughlin SR
Nature; 1994 Apr; 368(6472):648-51. PubMed ID: 8145852
[TBL] [Abstract][Full Text] [Related]
12. Ligand affinity for amino-terminal and juxtamembrane domains of the corticotropin releasing factor type I receptor: regulation by G-protein and nonpeptide antagonists.
Hoare SR; Sullivan SK; Schwarz DA; Ling N; Vale WW; Crowe PD; Grigoriadis DE
Biochemistry; 2004 Apr; 43(13):3996-4011. PubMed ID: 15049707
[TBL] [Abstract][Full Text] [Related]
13. Differential docking of high-affinity peptide ligands to type A and B cholecystokinin receptors demonstrated by photoaffinity labeling.
Dong M; Liu G; Pinon DI; Miller LJ
Biochemistry; 2005 May; 44(17):6693-700. PubMed ID: 15850403
[TBL] [Abstract][Full Text] [Related]
14. Use of constitutive G protein-coupled receptor activity for drug discovery.
Chen G; Way J; Armour S; Watson C; Queen K; Jayawickreme CK; Chen WJ; Kenakin T
Mol Pharmacol; 2000 Jan; 57(1):125-34. PubMed ID: 10617687
[TBL] [Abstract][Full Text] [Related]
15. Mapping of the extracellular binding regions of the human interleukin-8 type B receptor.
Katancik JA; Sharma A; Radel SJ; De Nardin E
Biochem Biophys Res Commun; 1997 Mar; 232(3):663-8. PubMed ID: 9126332
[TBL] [Abstract][Full Text] [Related]
16. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
[TBL] [Abstract][Full Text] [Related]
17. The G protein-coupling profile of metabotropic glutamate receptors, as determined with exogenous G proteins, is independent of their ligand recognition domain.
Parmentier ML; Joly C; Restituito S; Bockaert J; Grau Y; Pin JP
Mol Pharmacol; 1998 Apr; 53(4):778-86. PubMed ID: 9547371
[TBL] [Abstract][Full Text] [Related]
18. Inverse agonism: more than reverting constitutively active receptor signaling.
Dupré DJ; Rola-Pleszczynski M; Stanková J
Biochem Cell Biol; 2004 Dec; 82(6):676-80. PubMed ID: 15674435
[TBL] [Abstract][Full Text] [Related]
19. (S)-2-Amino-3-(3-hydroxy-7,8-dihydro-6H-cyclohepta[d]isoxazol-4-yl)propionic acid, a potent and selective agonist at the GluR5 subtype of ionotropic glutamate receptors. Synthesis, modeling, and molecular pharmacology.
Brehm L; Greenwood JR; Hansen KB; Nielsen B; Egebjerg J; Stensbøl TB; Bräuner-Osborne H; Sløk FA; Kronborg TT; Krogsgaard-Larsen P
J Med Chem; 2003 Apr; 46(8):1350-8. PubMed ID: 12672235
[TBL] [Abstract][Full Text] [Related]
20. Growth factor receptors: structure, mechanism, and drug discovery.
McInnes C; Sykes BD
Biopolymers; 1997; 43(5):339-66. PubMed ID: 9566117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
